APM Procedure Instrument with MatrixRecalls & reported problems across all models
Sonendo, Inc. · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names at least one APM Procedure Instrument with Matrix model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls
- 1
We found 2 models of APM Procedure Instrument with Matrix by Sonendo, Inc. in the FDA's device registry (GUDID). Together they are named in 3 adverse event reports in the FDA's MAUDE database, received between Mar 21, 2020 and Mar 21, 2020 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).
1 FDA recall record name at least one of these models by its device identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
APM Procedure Instrument with Matrix recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Oct 14, 2022Open, Classified
Procedure Instruments with erroneous unit carton labels.
Z-0233-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported APM Procedure Instrument with Matrix problems
Device problems
- Insufficient Device Problem Information3
Patient problems
- Swelling2
- Dyspnea1
- Hemorrhage/Blood Loss/Bleeding1
- No Code Available1
APM Procedure Instrument with Matrix models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- APM Procedure Instrument with Matrix FG-003-00011Scaler, Ultrasonic1 recall0 reports
- APM Procedure Instrument with Matrix FG-003-00010Scaler, Ultrasonic3 reports
Recent APM Procedure Instrument with Matrix adverse event reports
The 3 most recent reports across all models, in the reporter's own words as published by the FDA.
InjuryMar 21, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
THE DOCTOR REPORTED THAT THE PATIENT HAD A HYPOCHLORITE EXTRUSION INTO THE FACIAL TISSUES. THE PATIENT HAD IMMEDIATE PAIN AND SWELLING FOLLOWED BY BRUISING. PATIENT SOUGHT FOLLOW UP EMERGENCY TREATMENT FOR PAIN. PATIENT SEEMED OKAY AT 6 WEEK FOLLOW UP.
Patient problems: Swelling
MAUDE report 9863292 ↗InjuryMar 21, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
THE PROCEDURE WAS ON PATIENT'S UPPER MOLAR. ABOUT 90 SECONDS INTO THE NAOCI CYCLE, THE PATIENT RAISED HER HANDS AND SAID SHE WAS FEELING PAIN. THE DOCTOR DISCONTINUED THE GENTLEWAVE PROCEDURE, RINSED WITH DISTILLED WATER. SWELLING AND BRUISING WAS NOTED VERY QUICKLY. THE DOCTOR SENT THE PATIENT TO THE ENT IN THE BUILDING. THE PATIENT WAS GIVEN AN RX FOR STEROIDS AND PAIN MEDS. THE PATIENT HAD SWELLING AND BRUISING FOR A FEW WEEKS BUT IT EVENTUALLY RESOLVED AND SHE IS DOING FINE.
Patient problems: Swelling
MAUDE report 9863287 ↗InjuryMar 21, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
AFTER 4 MINUTES INTO THE NAOCI CYCLE, THE PATIENT JUMPED OUT OF THE CHAIR AND SAID HE COULD NOT BREATH. THERE WAS BLEEDING FROM THE TOOTH, BUT NOT EXCESSIVE. THE DOCTOR THOUGHT PATIENT INGESTED SOME NAOCI SO HE GAVE THE PATIENT WATER TO RINSE; AND AFTER FEW MINUTES THE PATIENT WAS ABLE TO CONTINUE WITH THE TREATMENT. THE TREATMENT WAS COMPLETED. THE PATIENT DID NOT HAVE SWELLING OR BRUISING AT THE TIME. HOWEVER, THE PATIENT WAS IN ER THAT NIGHT WHEN THE DOCTOR CALLED TO FOLLOW-UP. THE PATIENT STATED HE HAD EXCESSIVE AMOUNT OF NOSE BLEED AND HAD DIFFICULTY IN BREATHING. THE PATIENT WAS SENT HOME WITH AUGMENTIN 875MG EVERY 12 HOURS FOR 7 DAYS. AFTER 8 DAYS FOLLOWING THE INCIDENT, THE PATIENT CLAIMED HE WAS STILL CONGESTED, BUT NOSE BLEEDING HAD STOPPED. THE PATIENT HAS A FOLLOW-UP APPOINTMENT WITH HIS PHYSICIAN (GENERAL PRACTITIONER). THE DOCTOR ASKED THE PATIENT TO SCHEDULE AN APPOINTMENT FOLLOWING THE APPOINTMENT WITH HIS PHYSICIAN.
Patient problems: Dyspnea; Hemorrhage/Blood Loss/Bleeding; No Code Available
MAUDE report 9863280 ↗
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page